TABLE 1.
Mode of action | ERVb | Species (examples) | Molecular mechanisma | Target virus(es) | Reference(s) |
---|---|---|---|---|---|
Induction of sensing via nucleic acids | Multiple ERVs (e.g., ERV3-2, ERV4700) | Humans | Sensing of ERV-derived nucleic acids by MDA5, RIG-I, and TLR3 | Most likely several viruses | 15, 20–23 |
ALVE1 | Chickens | Induction of TLR3 signaling by ERV-derived lncRNA (lnc-ALVE1-AS1) | Avian leukosis virus subgroup J, possibly others | 18 | |
Regulation of immune signaling by lncRNAs | lnc-EPAV | Mice | lncRNA-mediated sequestration of SFPQ, a repressor of Rela expression | VSV, possibly others | 25 |
MER9a2, LTR5A, MLT2A1 | Humans | Binding of SFPQ; induction of Rela expression (?) | Most likely several viruses | 25 | |
Modulation of immune activation by ERV proteins | HERV-W Env | Humans | Activation of TLR4/CD14; induction of IL-1β, IL-6, TNF-α, and IL-12p40 | Most likely several viruses | 26 |
HERV-K(HML2) dUTPase | Humans | Activation of NF-κB via TLR2; induction of IL-1β, IL-6, IL-8, IL-10, IL-12p40, IL-23, IL-17, TNF-α, RANTES, IFN-γ, and CCL20 | Most likely several viruses | 28 | |
Receptor interference | ev3, ev6, ev9 | Chickens | Receptor blockade | Avian leukosis virus, subgroup E | 40 |
Fv-4r (Akvr-1) | Mice | Blockade of the receptor CAT-1 | Ecotropic murine leukemia viruses | 41, 42, 46 | |
Rcmf, Rcmf2 | Mice | Blockade of the receptor XPR1 | Polytropic murine leukemia viruses | 47–51 | |
en-JSRV env loci | Sheep | Blockade of the receptor hyaluronidase 2 (HYAL2) | Jaagsiekte sheep retrovirus, enzootic nasal tumor virus (?) | 52 | |
Refrex-1 (loci ERV-DC7 and –DC16) | Cats | Secreted truncated Env; extracellular receptor interference | Endogenous and exogenous feline retroviruses (ERV-DC genotype I, FeLV-D) | 54 | |
FeLIX | Cats | Secreted truncated Env; extracellular receptor interference | FeLV-B | 55 | |
HERV-T env locus | Primates | Depletion of MCT-1 from the cell surface | Extinct HERV-T ancestor | 56 | |
Suppressyn | Primates | Blockade of the receptor ASCT2 | RD114/mammalian type-D retroviruses | 57 | |
Dominant negative virion complementation | Fv-4r | Mice | Virion incorporation of Env with inactive fusion peptide | Ecotropic murine leukemia viruses | 58 |
HERV-K gag locus | Humans | Coassembly with exogenous viral Gag; generation of malformed and poorly infectious virions; reduced virion release | HIV-1 | 62, 63 | |
enJS56A1, enJSRV-20 (?) | Sheep | Dominant negative interference of a defective Gag protein with viral exit | Jaagsiekte sheep retrovirus | 64–66 | |
Interference with incoming viral particles | Fv1 | Mice | Binding to incoming capsids | Murine leukemia viruses | 67–70 |
Increased plasticity of immune genes | Multiple ERVs | Several species | Gene conversion and duplication events increasing the diversity of MHC II genes and potentially others | Most likely several viruses | 85 |
Regulation of antiviral gene expression | X-MLV LTR | Mice | Enhancer of mA3; increase in the levels and antiviral activity of APOBEC3 | MMTV, potentially others | 91, 92 |
HERVP71A LTR/enhancer L | Humans | Enhancer of HLA-G | Unclear | 93, 94 | |
MER41 | Humans | IFN-γ-inducible enhancer of AIM2 expression | Most likely several viruses | 97 | |
MER41 | Humans | IFN-γ-inducible enhancer of IFI6 expression | Several flaviviruses | 97 | |
MER41 | Humans | IFN-γ-inducible enhancer of SECTM1 expression | Most likely several viruses | 97 | |
ERV9 | Apes | Transcription start site for IRGM | Active against mycobacteria, antiviral activity unclear | 105 | |
LTR12C | Humans | IFN-γ-inducible promoter of GBP2 | HIV, measles virus, Zika virus, and other furin-dependent viral pathogens | 107 | |
LTR12C | Humans | Promoter of GBP5 | HIV, measles virus, Zika virus, and other furin-dependent viral pathogens | 107 | |
LTR12C | Humans | Promoter of SEMA4D (?) | Multiple viruses? | 107 |
TLR, Toll-like receptor; IL, interleukin; TNF-α, tumor necrosis factor alpha; IFN-γ, gamma interferon; lncRNA, long noncoding RNA.
LTR, long terminal repeat.